EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Past, Present, and Future of Cardiac Gene Therapy

Roger J Hajjar

Canadian Journal of Cardiology · 2026-05 · 42 (5) · 905-916

DOI: 10.1016/j.cjca.2026.01.035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2026-05. Verfasst von Roger J Hajjar. Beteiligte Einrichtung: Gene and Cell Therapy Institute, Mass General Brigham, Cambridge, Massachusetts, USA. Electronic address: rhajjar@mgb.org. Hauptthemen laut MEDLINE: Genetic Therapy, Cardiovascular Diseases, Heart Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mass General Brigham Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of gene therapy has undergone significant advancement in the last decade. Originally restricted to experimental biology, gene therapy is now an established clinical modality with demonstrated efficacy in addressing a range of diseases, particularly rare monogenic disorders, hematologic conditions, and oncologic applications. Nevertheless, the cardiovascular system presents both substantial challenges and notable opportunities for innovation in gene therapy. Cardiovascular disease continues to be the leading cause of mortality worldwide. Although advancements have been made in pharmacologic treatments, medical devices, and lifestyle modifications, current interventions do not fundamentally address the molecular mechanisms underlying most cardiac diseases. Gene therapy offers distinct potential to modify disease processes at the molecular and cellular level, providing prospects for durable or potentially curative solutions in heart failure, cardiomyopathies, arrhythmias, and vascular pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyCardiovascular DiseasesHeart DiseasesHumansGene Therapy Agents

Stichwörter der Autor:innen

adeno-associated vectorscardiomyopathiesgene therapygeneticheart failureimmunitymolecular

Autor:innen und Institutionen

  • Gene and Cell Therapy Institute, Mass General Brigham, Cambridge, Massachusetts, USA. Electronic address: rhajjar@mgb.org.

Förderung

  • Mass General Brigham Inc

Zitieren

APA

Hajjar, R. J. (2026). The Past, Present, and Future of Cardiac Gene Therapy. Canadian Journal of Cardiology, 42(5), 905-916. https://doi.org/10.1016/j.cjca.2026.01.035

Vancouver

Hajjar RJ. The Past, Present, and Future of Cardiac Gene Therapy. Canadian Journal of Cardiology. 2026;42(5):905-916. doi:10.1016/j.cjca.2026.01.035

BibTeX
@article{Hajjar2026,
  author = {Hajjar, Roger J},
  title = {The Past, Present, and Future of Cardiac Gene Therapy},
  journal = {Canadian Journal of Cardiology},
  year = {2026},
  volume = {42},
  number = {5},
  pages = {905--916},
  doi = {10.1016/j.cjca.2026.01.035}
}
Kostenlos starten →